Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.

Abstract

To determine incidence of invasive Haemophilus influenzae type b (Hib) disease in a defined population of Jeonbuk Province, Korea, children <5 years were evaluated in prospective, population-based surveillance of invasive bacterial diseases using standardized methods for patient referral, clinical evaluation and laboratory testing (optimized culture, latex agglutination, polymerase chain reaction). Vaccine utilization was assessed with vaccination histories of patients in surveillance, monthly data on Hib vaccine distribution and a coverage survey of clinic patients in study population. From September 1999 to December 2001, 2176 children were evaluated for possible meningitis, 1541 had no cerebrospinal fluid (CSF) findings of meningitis, 605 had CSF abnormalities (suspected bacterial meningitis) but no pathogen identified; six patients had probable Hib meningitis and eight had confirmed Hib meningitis. The annual suspected bacterial meningitis incidence was 258.4/100,000 <5 years and the probable/confirmed Hib meningitis incidence was 6.0/100,000 <5 years. Pneumococcal meningitis incidence was 2.1/100,000 <5 years and Group B streptococcal meningitis incidence was 0.17/1000 live births. A total of 69,589 Hib vaccine doses were distributed during the study. Hib vaccine coverage was negligible initially but increased to 16% (complete Hib immunization) and 27% (partial immunization) in final months of study. Suspected bacterial meningitis incidence was high but proven invasive Hib meningitis incidence was low. Hib was leading cause of bacterial meningitis yet bacterial pathogens were identified in only 4% of abnormal CSF. These findings may reflect truly low incidence, presumptive antibiotic treatment, partial Hib immunization, or incomplete clinical evaluations. Given the apparent Hib meningitis burden in Jeonbuk Province, additional studies to describe other invasive Hib syndromes, Hib-associated mortality and disability, and economic impact of Hib disease will be useful to guide public health decisions regarding routine Hib vaccine introduction.

• Authors: J S Kim, Y T Jang, J D Kim, T H Park, J M Park, P E Kilgore, W A Kennedy, E Park, B Nyambat, D R Kim, P H Hwang, S J Kim, S H Eun, H S Lee, J H Cho, Y S Kim, S J Chang, H F Huang, J D Clemens, J I Ward
• Journal: Vaccine (Vaccine) Vol. 22 Issue 29-30 Pg. 3952-62 (Sep 28 2004) ISSN: 0264-410X [Print] Netherlands
• PMID: 15364444 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Haemophilus Vaccines
• Vaccines, Conjugate

Topics

• Adolescent
• Adult
• Cerebrospinal Fluid (microbiology)
• Child
• Child, Preschool
• Female
• Haemophilus Infections (epidemiology, microbiology, prevention & control)
• Haemophilus Vaccines
• Haemophilus influenzae type b (isolation & purification)
• Humans
• Incidence
• Infant
• Infant, Newborn
• Korea (epidemiology)
• Male
• Meningitis, Bacterial (epidemiology, microbiology, prevention & control)
• Meningitis, Haemophilus (epidemiology, microbiology)
• Middle Aged
• Prospective Studies
• Streptococcus agalactiae (isolation & purification)
• Streptococcus pneumoniae (isolation & purification)
• Vaccines, Conjugate